Unique ID issued by UMIN | UMIN000034749 |
---|---|
Receipt number | R000039545 |
Scientific Title | Telemedicine vs hospital based medicine for assessment of Helicobacter pylori eradication: randomised controlled trial |
Date of disclosure of the study information | 2018/11/06 |
Last modified on | 2020/02/06 13:35:43 |
Telemedicine vs hospital based medicine for assessment of Helicobacter pylori eradication: randomised controlled trial
RCT of Telemedicine for assessment of Helicobacter pylori eradication
Telemedicine vs hospital based medicine for assessment of Helicobacter pylori eradication: randomised controlled trial
RCT of Telemedicine for assessment of Helicobacter pylori eradication
Japan |
Helicobacter pylori infection
Gastroenterology |
Others
NO
To compare the telemedicine and hospital based medicine in the assessment of Helicobacter pylori eradication therapy success about the following points:
(1) Reliability and compliance of the Urea Breath Test
(2) Questionnaire based evaluation by patient
Efficacy
Eradication rate (ITT analysis) and assessment of burden by questionnaire
Eradication rate (PP analysis)
Interventional
Parallel
Randomized
Individual
Open -no one is blinded
Active
2
Diagnosis
Other |
Telemedicine:Urea breath test at home by patient and breath bag is sent by post for the assessment of Helicobacter pylori eradication success and result description by the telemedicine system
Hospital based medicine:Assessment of Helicobacter pylori eradication success by urea breath test and result description at the hospital
20 | years-old | <= |
65 | years-old | >= |
Male and Female
(1)A patient with Helicobacter pylori infection without history of eradication therapy
(2)A patient who is willing to eradicate the Helicobacter pylori with triple therapy (containing amoxicillin + clarithromycin or metronidazole)
(3)A patient who understand the risk of telemedicine system, agreed the terms of use and expected to participate
(4)A patient who agreed not to storage or leak the video and voice of telemedicine
(5)A patient who give a written informed consent
(1)Patients allergic to penicillin
(2)Pregnancy
(3)Lactation
(4)A patient with brain and spinal cord disease
(5)A patient with infectious mononucleosis
(6)Severe liver dysfunction, severe renal dysfunction, severe heart dysfunction
172
1st name | Soichiro |
Middle name | |
Last name | Sue |
Yokohama City University Hospital
Gastroenterology
236-0004
Fukuura3-9, Kanazawa, Yokohama, Kanagawa, Japan
045-787-2326
ssue@yokohama-cu.ac.jp
1st name | Soichiro |
Middle name | |
Last name | Sue |
Yokohama City University Hospital
Gastroenterology
236-0004
Fukuura3-9, Kanazawa, Yokohama, Kanagawa, Japan
045-787-2326
ssue@yokohama-cu.ac.jp
Yokohama City University Hospital
Takeda Japan Medical Affairs Funded Research Grant
Profit organization
Japan
Yokohama City University Ethics Committee
Fukuura 3-9, Kanazawa-ku, Yokohama city, Kanagawa
045-370-7627
rinri@yokohama-cu.ac.jp
NO
2018 | Year | 11 | Month | 06 | Day |
Unpublished
Open public recruiting
2018 | Year | 07 | Month | 09 | Day |
2018 | Year | 07 | Month | 17 | Day |
2018 | Year | 11 | Month | 06 | Day |
2023 | Year | 03 | Month | 31 | Day |
2018 | Year | 11 | Month | 02 | Day |
2020 | Year | 02 | Month | 06 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000039545
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |